These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 15810718

  • 1. [Urinary incontinence: anticholinergic treatment].
    Jimenez Cidre MA.
    Rev Med Univ Navarra; 2004; 48(4):37-42. PubMed ID: 15810718
    [Abstract] [Full Text] [Related]

  • 2. Maximizing anticholinergic therapy for overactive bladder: has the ceiling been reached?
    MacDiarmid SA.
    BJU Int; 2007 Jun; 99 Suppl 3():8-12. PubMed ID: 17488367
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Newer agents for the management of overactive bladder.
    Epstein BJ, Gums JG, Molina E.
    Am Fam Physician; 2006 Dec 15; 74(12):2061-8. PubMed ID: 17186712
    [Abstract] [Full Text] [Related]

  • 6. [Anticholinergic drugs in overactive bladder].
    Muhlstein J, Deval B.
    Gynecol Obstet Fertil; 2008 Jan 15; 36(1):90-6. PubMed ID: 18178506
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Impact on cognitive function of anticholinergic drugs used for the treatment of overactive bladder in the elderly].
    Kerdraon J, Robain G, Jeandel C, Mongiat Artus P, Gamé X, Fatton B, Scheiber-Nogueira MC, Vetel JM, Mares P, Petit AC, Amarenco G, Groupe de recherche appliquée à la pelvi-périnéologie de la personne âgée (GRAPPPA).
    Prog Urol; 2014 Sep 15; 24(11):672-81. PubMed ID: 25214448
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacological agents for the treatment of urinary incontinence due to overactive bladder.
    Wein AJ.
    Expert Opin Investig Drugs; 2001 Jan 15; 10(1):65-83. PubMed ID: 11116281
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Short- and long-term efficacy of solifenacin treatment in patients with symptoms of mixed urinary incontinence.
    Staskin DR, Te AE.
    BJU Int; 2006 Jun 15; 97(6):1256-61. PubMed ID: 16686722
    [Abstract] [Full Text] [Related]

  • 14. Antimuscarinic drug inhibits detrusor overactivity induced by topical application of prostaglandin E2 to the urethra with a decrease in urethral pressure.
    Yokoyama O, Miwa Y, Oyama N, Aoki Y, Ito H, Akino H.
    J Urol; 2007 Nov 15; 178(5):2208-12. PubMed ID: 17870108
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Current diagnostics and therapy of the overactive bladder and urge incontinence].
    Badawi JK, Langbein S.
    Dtsch Med Wochenschr; 2005 Jun 17; 130(24):1503-6. PubMed ID: 15942840
    [Abstract] [Full Text] [Related]

  • 17. Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions?
    Finney SM, Andersson KE, Gillespie JI, Stewart LH.
    BJU Int; 2006 Sep 17; 98(3):503-7. PubMed ID: 16925744
    [Abstract] [Full Text] [Related]

  • 18. Selective beta-adrenoceptor agonists, calcium antagonists and potassium channel openers as a possible medical treatment of the overactive bladder and urge incontinence.
    Badawi JK, Langbein S.
    Pharmazie; 2006 Mar 17; 61(3):175-8. PubMed ID: 16599254
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients.
    Kay GG, Abou-Donia MB, Messer WS, Murphy DG, Tsao JW, Ouslander JG.
    J Am Geriatr Soc; 2005 Dec 17; 53(12):2195-201. PubMed ID: 16398909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.